MALBOROUGH, Mass., Aug. 25, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Morgan Stanley Global Healthcare Conference on September 8 in New York, NY.

Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 35-minute question and answer session regarding the company beginning at approximately 9:55 a.m. ET.

A live webcast of the question and answer session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Morgan Stanley.  A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS
Media:
Denise Kaigler
508-683-4449 (office)
Corporate Affairs & Communications
Boston Scientific Corporation
denise.kaigler@bsci.com

Investors:
Susie Lisa, CFA
508-683-5565 (office)
Investor Relations
Boston Scientific Corporation   
investor_relations@bsci.com

SOURCE Boston Scientific Corporation